{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:27:05Z","timestamp":1780086425084,"version":"3.54.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,1,3]]},"DOI":"10.1038\/s41388-021-02072-1","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T13:04:49Z","timestamp":1634821489000},"page":"72-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma"],"prefix":"10.1038","volume":"41","author":[{"given":"Wenli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulin","family":"Aerbajinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Botos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4710-0012","authenticated-orcid":false,"given":"Griffin P.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"2072_CR1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrclinonc.2013.132","volume":"10","author":"K Raghav","year":"2013","unstructured":"Raghav K, Overman MJ. Small bowel adenocarcinomas-existing evidence and evolving paradigms. Nat Rev Clin Oncol. 2013;10:534\u201344.","journal-title":"Nat Rev Clin Oncol"},{"key":"2072_CR2","first-page":"2207","volume":"11","author":"DH van Weering","year":"1995","unstructured":"van Weering DH, Medema JP, van Puijenbroek A, Burgering BM, Baas PD, Bos JL. Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. Oncogene. 1995;11:2207\u201314.","journal-title":"Oncogene"},{"key":"2072_CR3","doi-asserted-by":"crossref","first-page":"33577","DOI":"10.1074\/jbc.M605604200","volume":"281","author":"PP Knowles","year":"2006","unstructured":"Knowles PP, Murray-Rust J, Kjaer S, Scott RP, Hanrahan S, Santoro M, et al. Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem. 2006;281:33577\u201387.","journal-title":"J Biol Chem"},{"key":"2072_CR4","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1242\/jcs.00786","volume":"116","author":"H Sariola","year":"2003","unstructured":"Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci. 2003;116:3855\u201362.","journal-title":"J Cell Sci"},{"key":"2072_CR5","doi-asserted-by":"crossref","first-page":"a009233","DOI":"10.1101\/cshperspect.a009233","volume":"5","author":"M Santoro","year":"2013","unstructured":"Santoro M, Carlomagno F. Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol. 2013;5:a009233.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2072_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","volume":"7","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7:569\u201380.","journal-title":"Nat Rev Endocrinol"},{"key":"2072_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0092-8674(90)90659-3","volume":"60","author":"M Grieco","year":"1990","unstructured":"Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 1990;60:557\u201363.","journal-title":"Cell"},{"key":"2072_CR8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.133645.111","volume":"22","author":"YS Ju","year":"2012","unstructured":"Ju YS, Lee WC, Shin JY, Lee S, Bleazard T, Won JK, et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res. 2012;22:436\u201345.","journal-title":"Genome Res"},{"key":"2072_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","volume":"18","author":"T Kohno","year":"2012","unstructured":"Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, et al. KIF5B-RET fusions in lung adenocarcinoma. Nat Med. 2012;18:375\u20137.","journal-title":"Nat Med"},{"key":"2072_CR10","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/leu.2012.109","volume":"26","author":"P Ballerini","year":"2012","unstructured":"Ballerini P, Struski S, Cresson C, Prade N, Toujani S, Deswarte C, et al. RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation. Leukemia. 2012;26:2384\u20139.","journal-title":"Leukemia"},{"key":"2072_CR11","doi-asserted-by":"crossref","first-page":"28929","DOI":"10.18632\/oncotarget.4325","volume":"6","author":"AF Le Rolle","year":"2015","unstructured":"Le Rolle AF, Klempner SJ, Garrett CR, Seery T, Sanford EM, Balasubramanian S, et al. Identification and characterization of RET fusions in advanced colorectal cancer. Oncotarget. 2015;6:28929\u201337.","journal-title":"Oncotarget"},{"key":"2072_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10555-016-9624-2","volume":"35","author":"W Liu","year":"2016","unstructured":"Liu W, Rodgers GP. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer. Cancer Metastasis Rev. 2016;35:201\u201312.","journal-title":"Cancer Metastasis Rev"},{"key":"2072_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-1119(01)00763-6","volume":"283","author":"J Zhang","year":"2002","unstructured":"Zhang J, Liu WL, Tang DC, Chen L, Wang M, Pack SD, et al. Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene. 2002;283:83\u201393.","journal-title":"Gene"},{"key":"2072_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.gastro.2009.05.035","volume":"137","author":"LG van der Flier","year":"2009","unstructured":"van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology. 2009;137:15\u201317.","journal-title":"Gastroenterology"},{"key":"2072_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2559.2007.02763.x","volume":"51","author":"W Liu","year":"2007","unstructured":"Liu W, Zhu J, Cao L, Rodgers GP. Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology. 2007;51:157\u201365.","journal-title":"Histopathology"},{"key":"2072_CR16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1158\/1078-0432.CCR-07-4125","volume":"14","author":"W Liu","year":"2008","unstructured":"Liu W, Liu Y, Zhu J, Wright E, Ding I, Rodgers GP. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin Cancer Res. 2008;14:1041\u20139.","journal-title":"Clin Cancer Res"},{"key":"2072_CR17","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1038\/onc.2016.58","volume":"35","author":"W Liu","year":"2016","unstructured":"Liu W, Li H, Hong SH, Piszczek GP, Chen W, Rodgers GP. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc mice. Oncogene. 2016;35:5237\u201347.","journal-title":"Oncogene"},{"key":"2072_CR18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jmoldx.2017.05.006","volume":"19","author":"JW Reeser","year":"2017","unstructured":"Reeser JW, Martin D, Miya J, Kautto EA, Lyon E, Zhu E, et al. Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors. J Mol Diagn. 2017;19:682\u201396.","journal-title":"J Mol Diagn"},{"key":"2072_CR19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00125480-200111000-00005","volume":"8","author":"G Tallini","year":"2001","unstructured":"Tallini G, Asa SL. RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol. 2001;8:345\u201354.","journal-title":"Adv Anat Pathol"},{"key":"2072_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc3680","volume":"14","author":"LM Mulligan","year":"2014","unstructured":"Mulligan LM. RET revisited: expanding the oncogenic portfolio. Nat Rev Cancer. 2014;14:173\u201386.","journal-title":"Nat Rev Cancer"},{"key":"2072_CR21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1210\/me.2002-0401","volume":"17","author":"JH Hwang","year":"2003","unstructured":"Hwang JH, Kim DW, Suh JM, Kim H, Song JH, Hwang ES, et al. Activation of signal transducer and activator of transcription 3 by oncogenic RET\/PTC (rearranged in transformation\/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation. Mol Endocrinol. 2003;17:1155\u201366.","journal-title":"Mol Endocrinol"},{"key":"2072_CR22","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/onc.2012.225","volume":"32","author":"Y Luo","year":"2013","unstructured":"Luo Y, Tsuchiya KD, Il Park D, Fausel R, Kanngurn S, Welcsh P, et al. RET is a potential tumor suppressor gene in colorectal cancer. Oncogene. 2013;32:2037\u201347.","journal-title":"Oncogene"},{"key":"2072_CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","volume":"18","author":"D Lipson","year":"2012","unstructured":"Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med. 2012;18:382\u20134.","journal-title":"Nat Med"},{"key":"2072_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ydbio.2012.01.012","volume":"366","author":"V Sasselli","year":"2012","unstructured":"Sasselli V, Pachnis V, Burns AJ. The enteric nervous system. Dev Biol. 2012;366:64\u201373.","journal-title":"Dev Biol"},{"key":"2072_CR25","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.15252\/embj.201696247","volume":"36","author":"D Perea","year":"2017","unstructured":"Perea D, Guiu J, Hudry B, Konstantinidou C, Milona A, Hadjieconomou D, et al. Ret receptor tyrosine kinase sustains proliferation and tissue maturation in intestinal epithelia. Embo J. 2017;36:3029\u201345.","journal-title":"Embo J"},{"key":"2072_CR26","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/4.12.2313","volume":"4","author":"PA Smanik","year":"1995","unstructured":"Smanik PA, Furminger TL, Mazzaferri EL, Jhiang SM. Breakpoint characterization of the ret\/PTC oncogene in human papillary thyroid carcinoma. Hum Mol Genet. 1995;4:2313\u20138.","journal-title":"Hum Mol Genet"},{"key":"2072_CR27","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1074\/jbc.271.10.5309","volume":"271","author":"X Liu","year":"1996","unstructured":"Liu X, Vega QC, Decker RA, Pandey A, Worby CA, Dixon JE. Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities. J Biol Chem. 1996;271:5309\u201312.","journal-title":"J Biol Chem"},{"key":"2072_CR28","doi-asserted-by":"crossref","first-page":"14213","DOI":"10.1074\/jbc.M312600200","volume":"279","author":"Y Kawamoto","year":"2004","unstructured":"Kawamoto Y, Takeda K, Okuno Y, Yamakawa Y, Ito Y, Taguchi R, et al. Identification of RET autophosphorylation sites by mass spectrometry. J Biol Chem. 2004;279:14213\u201324.","journal-title":"J Biol Chem"},{"key":"2072_CR29","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1038\/onc.2010.179","volume":"29","author":"V Leone","year":"2010","unstructured":"Leone V, Mansueto G, Pierantoni GM, Tornincasa M, Merolla F, Cerrato A, et al. CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1. Oncogene. 2010;29:4341\u201351.","journal-title":"Oncogene"},{"key":"2072_CR30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1017938608460","volume":"67","author":"A Kollara","year":"2001","unstructured":"Kollara A, Kahn HJ, Marks A, Brown TJ. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res Treat. 2001;67:245\u201353.","journal-title":"Breast Cancer Res Treat"},{"key":"2072_CR31","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1093\/emboj\/19.15.4056","volume":"19","author":"MC Bordeaux","year":"2000","unstructured":"Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, et al. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. Embo J. 2000;19:4056\u201363.","journal-title":"Embo J"},{"key":"2072_CR32","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/sj.emboj.7601636","volume":"26","author":"C Ca\u00f1ibano","year":"2007","unstructured":"Ca\u00f1ibano C, Rodriguez NL, Saez C, Tovar S, Garcia-Lavandeira M, Borrello MG, et al. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1\/p53 pathway, preventing tumor growth. Embo j. 2007;26:2015\u201328.","journal-title":"Embo j"},{"key":"2072_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-795-2_1","volume":"661","author":"Y Keshet","year":"2010","unstructured":"Keshet Y, Seger R. The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol. 2010;661:3\u201338.","journal-title":"Methods Mol Biol"},{"key":"2072_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/bs.acr.2018.02.004","volume":"138","author":"ST Eblen","year":"2018","unstructured":"Eblen ST. Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes. Adv Cancer Res. 2018;138:99\u2013142.","journal-title":"Adv Cancer Res"},{"key":"2072_CR35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/00365520410005847","volume":"39","author":"H Bl\u00e4ker","year":"2004","unstructured":"Bl\u00e4ker H, Helmchen B, B\u00f6nisch A, Aulmann S, Penzel R, Otto HF, et al. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol. 2004;39:748\u201353.","journal-title":"Scand J Gastroenterol"},{"key":"2072_CR36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1210\/mend.14.11.0559","volume":"14","author":"JM Shirokawa","year":"2000","unstructured":"Shirokawa JM, Elisei R, Knauf JA, Hara T, Wang J, Saavedra HI, et al. Conditional apoptosis induced by oncogenic ras in thyroid cells. Mol Endocrinol. 2000;14:1725\u201338.","journal-title":"Mol Endocrinol"},{"key":"2072_CR37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.mce.2013.06.029","volume":"382","author":"HK Resemann","year":"2014","unstructured":"Resemann HK, Watson CJ, Lloyd-Lewis B. The Stat3 paradox: a killer and an oncogene. Mol Cell Endocrinol. 2014;382:603\u201311.","journal-title":"Mol Cell Endocrinol"},{"key":"2072_CR38","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1073\/pnas.0604042103","volume":"103","author":"DE Levy","year":"2006","unstructured":"Levy DE, Inghirami G. STAT3: a multifaceted oncogene. Proc Natl Acad Sci USA. 2006;103:10151\u20132.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2072_CR39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1210\/endo.137.1.8536638","volume":"137","author":"SM Jhiang","year":"1996","unstructured":"Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, et al. Targeted expression of the ret\/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology. 1996;137:375\u20138.","journal-title":"Endocrinology"},{"key":"2072_CR40","first-page":"1821","volume":"12","author":"M Santoro","year":"1996","unstructured":"Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, et al. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET\/PTC1 oncogene in transgenic mice. Oncogene. 1996;12:1821\u20136.","journal-title":"Oncogene"},{"key":"2072_CR41","first-page":"5523","volume":"58","author":"DJ Powell Jr.","year":"1998","unstructured":"Powell DJ Jr., Russell J, Nibu K, Li G, Rhee E, Liao M, et al. The RET\/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res. 1998;58:5523\u20138.","journal-title":"Cancer Res"},{"key":"2072_CR42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13:184\u201399.","journal-title":"Nat Rev Cancer"},{"key":"2072_CR43","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.yexcr.2006.02.011","volume":"312","author":"W Liu","year":"2006","unstructured":"Liu W, Chen L, Zhu J, Rodgers GP. The glycoprotein hGC-1 binds to cadherin and lectins. Exp Cell Res. 2006;312:1785\u201397.","journal-title":"Exp Cell Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02072-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T11:10:07Z","timestamp":1641208207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02072-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,3]]}},"alternative-id":["2072"],"URL":"https:\/\/doi.org\/10.1038\/s41388-021-02072-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}